Treatment with magnesium improves reference memory but not working memory while reducing GFAP expression following traumatic brain injury

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Purpose: Previous studies have shown that administration of MgCl 2 in animal models of brain injury significantly improves functional recovery: however, few studies have examined cognitive recovery. The present study evaluated the effect of MgCl2 pharmacotherapy on recovery of function following medial frontal cortex contusion injury. Methods: Groups of rats were assigned to either MgCl2 (1.0 mmol/kg) or saline treatment conditions and prepared with contusion injuries or shams. Drug treatment was administered 15 min and 24 hr following injury. Rats were examined on tests of sensorimotor performance (bilateral tactile adhesive removal) and cognitive ability (reference and working memory). Results: Administration of MgCl 2 following injury significantly reduced the behavioral impairments observed on the bilateral tactile removal test. The acquisition of reference memory was also significantly improved compared to saline-treated rats; however, treatment did not improve working memory performance. Lesion analysis revealed that administration of MgCl2 did not significantly reduce lesion size compared to saline-treatment. Examination of glial fibrillary acidic protein (GFAP) expression showed that MgCl2 did significantly reduce the number of GFAP+ cells. Conclusion: These results indicate that MgCl2 administration significantly improved behavioral outcome following injury in a task dependent manner and reduced GFAP expression.

Original languageEnglish (US)
Pages (from-to)67-77
Number of pages11
JournalRestorative Neurology and Neuroscience
Volume23
Issue number2
StatePublished - Sep 5 2005
Externally publishedYes

Fingerprint

Magnesium Chloride
Glial Fibrillary Acidic Protein
Short-Term Memory
Magnesium
Wounds and Injuries
Contusions
Touch
Therapeutics
Aptitude
Recovery of Function
Frontal Lobe
Adhesives
Brain Injuries
Animal Models
Traumatic Brain Injury
Drug Therapy
Pharmaceutical Preparations

Keywords

  • Cognition
  • Gliosis
  • MgCl
  • Neuroprotection
  • Neurotrauma
  • Rat
  • Recovery of function
  • Sensorimotor

ASJC Scopus subject areas

  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology

Cite this

@article{076645b565fd478093b700a3fd27f832,
title = "Treatment with magnesium improves reference memory but not working memory while reducing GFAP expression following traumatic brain injury",
abstract = "Purpose: Previous studies have shown that administration of MgCl 2 in animal models of brain injury significantly improves functional recovery: however, few studies have examined cognitive recovery. The present study evaluated the effect of MgCl2 pharmacotherapy on recovery of function following medial frontal cortex contusion injury. Methods: Groups of rats were assigned to either MgCl2 (1.0 mmol/kg) or saline treatment conditions and prepared with contusion injuries or shams. Drug treatment was administered 15 min and 24 hr following injury. Rats were examined on tests of sensorimotor performance (bilateral tactile adhesive removal) and cognitive ability (reference and working memory). Results: Administration of MgCl 2 following injury significantly reduced the behavioral impairments observed on the bilateral tactile removal test. The acquisition of reference memory was also significantly improved compared to saline-treated rats; however, treatment did not improve working memory performance. Lesion analysis revealed that administration of MgCl2 did not significantly reduce lesion size compared to saline-treatment. Examination of glial fibrillary acidic protein (GFAP) expression showed that MgCl2 did significantly reduce the number of GFAP+ cells. Conclusion: These results indicate that MgCl2 administration significantly improved behavioral outcome following injury in a task dependent manner and reduced GFAP expression.",
keywords = "Cognition, Gliosis, MgCl, Neuroprotection, Neurotrauma, Rat, Recovery of function, Sensorimotor",
author = "Hoane, {Michael R.}",
year = "2005",
month = "9",
day = "5",
language = "English (US)",
volume = "23",
pages = "67--77",
journal = "Restorative Neurology and Neuroscience",
issn = "0922-6028",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - Treatment with magnesium improves reference memory but not working memory while reducing GFAP expression following traumatic brain injury

AU - Hoane, Michael R.

PY - 2005/9/5

Y1 - 2005/9/5

N2 - Purpose: Previous studies have shown that administration of MgCl 2 in animal models of brain injury significantly improves functional recovery: however, few studies have examined cognitive recovery. The present study evaluated the effect of MgCl2 pharmacotherapy on recovery of function following medial frontal cortex contusion injury. Methods: Groups of rats were assigned to either MgCl2 (1.0 mmol/kg) or saline treatment conditions and prepared with contusion injuries or shams. Drug treatment was administered 15 min and 24 hr following injury. Rats were examined on tests of sensorimotor performance (bilateral tactile adhesive removal) and cognitive ability (reference and working memory). Results: Administration of MgCl 2 following injury significantly reduced the behavioral impairments observed on the bilateral tactile removal test. The acquisition of reference memory was also significantly improved compared to saline-treated rats; however, treatment did not improve working memory performance. Lesion analysis revealed that administration of MgCl2 did not significantly reduce lesion size compared to saline-treatment. Examination of glial fibrillary acidic protein (GFAP) expression showed that MgCl2 did significantly reduce the number of GFAP+ cells. Conclusion: These results indicate that MgCl2 administration significantly improved behavioral outcome following injury in a task dependent manner and reduced GFAP expression.

AB - Purpose: Previous studies have shown that administration of MgCl 2 in animal models of brain injury significantly improves functional recovery: however, few studies have examined cognitive recovery. The present study evaluated the effect of MgCl2 pharmacotherapy on recovery of function following medial frontal cortex contusion injury. Methods: Groups of rats were assigned to either MgCl2 (1.0 mmol/kg) or saline treatment conditions and prepared with contusion injuries or shams. Drug treatment was administered 15 min and 24 hr following injury. Rats were examined on tests of sensorimotor performance (bilateral tactile adhesive removal) and cognitive ability (reference and working memory). Results: Administration of MgCl 2 following injury significantly reduced the behavioral impairments observed on the bilateral tactile removal test. The acquisition of reference memory was also significantly improved compared to saline-treated rats; however, treatment did not improve working memory performance. Lesion analysis revealed that administration of MgCl2 did not significantly reduce lesion size compared to saline-treatment. Examination of glial fibrillary acidic protein (GFAP) expression showed that MgCl2 did significantly reduce the number of GFAP+ cells. Conclusion: These results indicate that MgCl2 administration significantly improved behavioral outcome following injury in a task dependent manner and reduced GFAP expression.

KW - Cognition

KW - Gliosis

KW - MgCl

KW - Neuroprotection

KW - Neurotrauma

KW - Rat

KW - Recovery of function

KW - Sensorimotor

UR - http://www.scopus.com/inward/record.url?scp=23944515527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944515527&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 67

EP - 77

JO - Restorative Neurology and Neuroscience

JF - Restorative Neurology and Neuroscience

SN - 0922-6028

IS - 2

ER -